VRCA

5.98

9.32% 0.51

Handel nachbörslich: 5.72 -0.26 -4.35%

Verrica Pharmaceuticals Inc (VRCA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$5.47

Offen:

$5.5

24-Stunden-Volumen:

75,392

Relative Volume:

0.52

Marktkapitalisierung:

$102.73M

Einnahmen:

$35.58M

Nettoeinkommen (Verlust:

$-17.89M

KGV:

-8.7645

EPS:

-0.6823

Netto-Cashflow:

$-17.74M

1W Leistung:

+25.63%

1M Leistung:

+12.62%

6M Leistung:

+27.51%

1J Leistung:

+12.81%

1-Tages-Spanne:

$5.50

$6.01

1-Wochen-Bereich:

$4.53

$6.01

52-Wochen-Spanne:

$3.28

$9.8212

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Firmenname

Verrica Pharmaceuticals Inc

Sektor

Healthcare (1116)

Branche

Biotechnology (624)

Telefon

484-453-3300

Adresse

10 NORTH HIGH STREET, WEST CHESTER, PA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-03-11

Neueste SEC-Einreichungen

VRCA's Discussions on Twitter

Compare VRCA vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VRCA Verrica Pharmaceuticals Inc	5.98	93.97M	35.58M	-17.89M	-17.74M	-0.6823
VRTX Vertex Pharmaceuticals Inc	434.30	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	763.04	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	748.25	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.34	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.81	35.01B	606.42M	-1.28B	-997.58M	-6.403

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-06	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-11-05	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2023-07-25	Hochstufung	Needham	Hold → Buy
2023-03-22	Eingeleitet	Jefferies	Buy
2023-02-13	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2022-05-25	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2021-05-14	Eingeleitet	RBC Capital Mkts	Outperform
2020-12-24	Bestätigt	H.C. Wainwright	Buy
2020-07-15	Herabstufung	BofA Securities	Buy → Neutral
2020-06-30	Bestätigt	H.C. Wainwright	Buy
2020-06-24	Eingeleitet	Northland Capital	Outperform
2020-03-24	Eingeleitet	Needham	Buy
2019-02-21	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten

08:00 AM

Needham conference adds Verrica CEO; webcast runs live April 15 - stocktitan.net

08:00 AM

Mar 31, 2026

Published on: 2026-04-01 04:27:23 - baoquankhu1.vn

Mar 31, 2026

Market Trends: How does Verrica Pharmaceuticals Inc score in quality rankingsProfit Target & Safe Swing Trade Setups - baoquankhu1.vn

Mar 31, 2026

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Large Growth in Short Interest - marketbeat.com

Mar 31, 2026

Published on: 2026-03-31 18:08:06 - baoquankhu1.vn

Mar 31, 2026

Mar 27, 2026

Common Warts Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Verrica Pharma, Kino Pharma, Iwaki Pharma, Aclaris Therapeutics, KinoPharma - Barchart.com

Mar 27, 2026

Mar 25, 2026

Nasdaq Moves: How does Verrica Pharmaceuticals Inc perform in inflationary periodsDollar Strength & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 25, 2026

Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference - MSN

Mar 25, 2026

Mar 23, 2026

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Mar 23, 2026

Verrica Pharmaceuticals reports 2025 results and YCANTH sales growth - MSN

Mar 23, 2026

Mar 20, 2026

Dip Buying: Is Verrica Pharmaceuticals Inc a turnaround story2026 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn

Mar 20, 2026

Verrica Pharmaceuticals appoints Chris Chapman as chief commercial officer - MSN

Mar 20, 2026

VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm - weeklyvoice.com

Mar 20, 2026

VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - weeklyvoice.com

Mar 20, 2026

Mar 19, 2026

Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - The Joplin Globe

Mar 19, 2026

Mar 17, 2026

Verrica Pharmaceuticals Q4 Loss Reignites Debate On Path To Sustainable Profitability - Sahm

Mar 13, 2026

Mar 12, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR) - The Globe and Mail

Mar 12, 2026

Mar 11, 2026

Verrica Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat

Mar 11, 2026

Verrica Pharmaceuticals Gains CHMP Support for YCANTH® Marketing Application in Europe - MSN

Mar 11, 2026

Verrica Pharmaceuticals Achieves 130% YCANTH Revenue Growth in 2025, Expands Global Pipeline, and Extends Cash Runway into 2027 - Minichart

Mar 11, 2026